Sanara MedTech Inc.
SMTI
$31.05
-$0.85-2.67%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 35.24% | 27.97% | 19.42% | 15.50% | 22.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.24% | 27.97% | 19.42% | 15.50% | 22.85% |
| Cost of Revenue | 13.74% | -8.17% | -11.09% | -24.52% | -21.42% |
| Gross Profit | 37.87% | 33.80% | 24.26% | 22.82% | 31.97% |
| SG&A Expenses | 33.76% | 27.83% | 24.85% | 17.93% | 15.05% |
| Depreciation & Amortization | 10.64% | 37.55% | 41.92% | 34.45% | 22.43% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.69% | 21.00% | 17.12% | 9.54% | 8.95% |
| Operating Income | 15.20% | 28.32% | 4.29% | 22.78% | 49.13% |
| Income Before Tax | -163.32% | -89.11% | -47.91% | 93.70% | 66.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -163.32% | -89.11% | -47.91% | 93.70% | 28.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -26.88% | -34.38% | -9.11% | -55.06% | -41.16% |
| Net Income | -169.50% | -91.72% | -49.78% | 94.22% | 27.89% |
| EBIT | 15.20% | 28.32% | 4.29% | 22.78% | 49.13% |
| EBITDA | 58.83% | 65.52% | 44.73% | 45.97% | 74.40% |
| EPS Basic | -163.55% | -86.23% | -45.39% | 94.41% | 29.82% |
| Normalized Basic EPS | -28.74% | 1.28% | -9.28% | 14.06% | 44.71% |
| EPS Diluted | -163.55% | -86.23% | -45.39% | 94.41% | 29.82% |
| Normalized Diluted EPS | -28.74% | 1.28% | -9.28% | 14.06% | 44.71% |
| Average Basic Shares Outstanding | 2.22% | 2.95% | 3.01% | 3.27% | 2.78% |
| Average Diluted Shares Outstanding | 2.22% | 2.95% | 3.01% | 3.27% | 2.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
